Company
Jasper Therapeutics Inc (NASDAQ:JSPR)’s 12-Month Price Target Currently Stands At 65
In last trading session, Jasper Therapeutics Inc (NASDAQ:JSPR) saw 0.35 million shares changing hands with its beta currently measuring 2.73. Company’s recent per share price